Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Surgical Sciences (NDS) is delighted to be taking part in Oxford's science and ideas festival this month.

IF Oxford is an annual science and ideas festival taking place in locations across the city. It offers a variety of events, workshops and talks to explore the latest scientific research with audiences of all ages, and creates an opportunity for thousands of face-to-face interactions between festival visitors, researchers and innovators.

NDS will be exhibiting in Oxford Town Hall within the Explorazone on Saturday 13 October and Sunday 14 October, from 12 noon to 5pm, and in The Oxford Academy, Littlemore on Sunday 21 October, from 12 noon to 5pm.

Oxford Town Hall

On Saturday 13 October, the team from the Surgical Intervention Trials Unit (SITU) will be discussing how you might go about comparing different surgical techniques and the research into whether training on modules improves surgeons performance in the operating theatre.

On Sunday 14 October, members from the Transplantation Research Immunology Group (TRIG) will be asking visitors 'The heroes and villains in transplantation - Can you sort them out?' In TRIG, the scientists try to find new ways to help transplants live longer by changing the balance of the body's immune system. Their interactive demonstration will show you how an upcoming clinical trial will sort 'good' protective cells from 'bad' cells that cause transplant rejection and how this might help save lives. Visitors will also be able to test their knowledge of human anatomy on an anatomy model.

Littlemore life lab, THE OXFORD ACADEMY

On Sunday 21 October, the Oxford Transplant Centre (The COPE Consortium and QUOD) will showcase the research they are doing into making more organs useful for transplant, which will help close the critical gap between supply and demand in organ transplant. Visitors will see an organ perfusion machine, learning about the power of new technologies in organ preservation, and will be able to practice taking biopsies using fruit instead of organs whilst the team explain how taking such biopsies throughout the transplant process enables their research.

 

This year's IF Oxford festival runs from 12- 22 October. View the full programme.

Similar stories

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

JNDS: new issue out now

Department Publication

Journal of the Nuffield Department of Surgical Sciences (JNDS) has published its next issue, featuring top case reports written by University of Oxford medical students during their clinical studies.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Transplant kidney survival rate improves with new method of transportation

Publication Research

New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.